Common genetic fusion event may be associated with low-risk prostate cancer

(American Association for Cancer Research) Establishing the way in which a genetic alteration called a TMPRSS2-ERG gene fusion forms in a prostate cancer, rather than the presence of the gene fusion itself, could help identify patients with prostate cancer with a low risk of spreading, which might determine the best course of treatment for the patient.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news